Adial Pharmaceuticals, Inc (ADIL) Financial Statements (2024 and earlier)

Company Profile

Business Address 1180 SEMINOLE TRAIL
CHARLOTTESVILLE, VA 22901
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,0026,0624,4016,7773,869
Cash and cash equivalents4,0026,0624,4016,7773,869
Receivables     
Prepaid expense 42910233831506
Intangible current assets   11 
Other undisclosed current assets34939050164318
Total current assets:4,7806,4625,1367,6734,693
Noncurrent Assets
Operating lease, right-of-use asset 194246  
Property, plant and equipment 5058   
Long-term investments and receivables     
Long-term investments     
Intangible assets, net (including goodwill)2532546  
Goodwill 249249   
Intangible assets, net (excluding goodwill)456  
Other noncurrent assets    67
Other undisclosed noncurrent assets 455455350  
Total noncurrent assets:9531,01335667
TOTAL ASSETS:5,7337,4755,4917,6804,699
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,5492,6631,505539258
Accounts payable394286649190 
Accrued liabilities1,1552,377857349 
Other undisclosed accounts payable and accrued liabilities     258
Debt 5750   
Due to related parties175    
Other liabilities1010   
Other undisclosed current liabilities     
Total current liabilities:1,7912,7221,505539258
Noncurrent Liabilities
Long-term debt and lease obligation:  207   
Liabilities, other than long-term debt 17323   
Deferred income tax liabilities 2323  
Operating lease, liability 151207  
Other undisclosed noncurrent liabilities 4921,014   
Total noncurrent liabilities: 6651,245   
Total liabilities:2,4563,9671,505539258
Equity
Equity, attributable to parent3,2763,5083,9867,1414,441
Common stock272114107
Additional paid in capital66,92454,43035,49127,75716,470
Accumulated deficit(63,675)(50,943)(31,520)(20,627)(12,035)
Total equity:3,2763,5083,9867,1414,441
TOTAL LIABILITIES AND EQUITY:5,7337,4755,4917,6804,699

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues 46376  
Other operating income   376  
Other income 46   
Cost of revenue
(Financing Interest Expense)
     (1,167)
Gross profit: 46376 (1,167)
Operating expenses(13,317)(19,289)(10,928)(8,245)(6,987)
Other undisclosed operating income (loss) (46)(376) 1,167
Operating loss:(13,317)(19,289)(10,928)(8,245)(6,987)
Nonoperating income (expense)585(229)35(347)(4,644)
Investment income, nonoperating585(275)32957
Interest and debt expense     (5)
Loss from continuing operations before equity method investments, income taxes:(12,732)(19,517)(10,893)(8,591)(11,636)
Other undisclosed income from continuing operations before income taxes     5
Loss from continuing operations before income taxes:(12,732)(19,517)(10,893)(8,591)(11,631)
Income tax expense (benefit) 194446(14,246) 
Other undisclosed income from continuing operations     
Loss from continuing operations:(12,731)(19,423)(10,447)(22,838)(11,631)
Loss before gain (loss) on sale of properties:(19,423)(10,447)(22,838)(11,631)
Income from discontinued operations     
Other undisclosed net income (loss)   (446)14,246 
Net loss available to common stockholders, diluted:(12,731)(19,423)(10,893)(8,591)(11,631)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(12,731)(19,423)(10,893)(8,591)(11,631)
Comprehensive loss, net of tax, attributable to parent:(12,731)(19,423)(10,893)(8,591)(11,631)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: